9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia

Hypoxic-Ischemic Encephalopathy (HIE) & Therapeutic Hypothermia

Hypoxic-ischemic encephalopathy (HIE) resulting from acute perinatal asphyxia is a primary cause of neonatal mortality and long-term neurodevelopmental impairment, including spastic cerebral palsy, sensorineural deafness, microcephaly, and cognitive deficits. Therapeutic hypothermia initiated within a strict six-hour therapeutic window provides robust neuroprotection by dampening secondary biochemical cascades. For the neonatal transport specialist, recognizing eligibility, establishing precise core temperature monitoring, initiating controlled cooling, and preventing the life-threatening consequences of uncontrolled overcooling are critical transport competencies.

---

Pathophysiology of Perinatal Asphyxia & Triphasic Brain Injury

Perinatal asphyxia occurs when severe impairment of placental or pulmonary gas exchange leads to progressive hypoxemia, hypercapnia, and metabolic acidosis. The resulting neurological injury does not occur as a single static event, but rather unfolds across a well-defined triphasic continuum.

1. Primary Energy Failure (Acute Insult)

During the primary sentinel asphyxial event (e.g., complete placental abruption, uterine rupture, umbilical cord prolapse, or sustained fetal terminal bradycardia), cerebral blood flow and oxygen delivery fall below critical thresholds.

• Cellular Depolarization: Depletion of cellular oxygen halts mitochondrial oxidative phosphorylation, precipitating an immediate exhaustion of high-energy adenine nucleotides (adenosine triphosphate [ATP] and phosphocreatine [PCr]).
• Ion Pump Arrest & Cytotoxic Edema: Loss of ATP deactivates the energy-dependent Na+/K+-ATPase and Ca2+-ATPase membrane pumps. Intracellular sodium, chloride, and water accumulate rapidly, causing acute cytotoxic edema, while massive membrane depolarization triggers unchecked extracellular glutamate accumulation and toxic calcium influx.
• Lactic Acidosis: Anaerobic glycolysis ensues, generating intracellular lactic acid, tissue acidosis, and early cellular swelling.

2. The Latent Phase (The 0 to 6 Hour Window of Opportunity)

Following successful cardiopulmonary resuscitation and restoration of systemic perfusion, cerebral cellular metabolism partially normalizes. Phosphocreatine and ATP stores transiently recover, and microvascular blood flow temporarily stabilizes. This latent phase lasts approximately 6 hours.

• The Critical Window: Although cells appear biochemically recovered, submicroscopic apoptotic signaling pathways have already been triggered. Therapeutic hypothermia must be initiated during this 6-hour latent window before secondary energy failure begins. Cooling applied after 6 hours fails to prevent downstream enzymatic activation and provides negligible neuroprotection.

3. Secondary Energy Failure (6 to 72+ Hours)

Beginning approximately 6 to 12 hours after the initial insult and peaking at 24 to 72 hours, secondary energy failure develops without any new hypoxic event:

• Mitochondrial Permeability Transition Pore (mPTP) Opening: Massive calcium overload induces mitochondrial membrane collapse and release of cytochrome c into the cytoplasm.
• Excitotoxicity & Free Radical Cascades: Excessive glutamate overactivates post-synaptic N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, releasing toxic reactive oxygen species (ROS), peroxynitrite, and nitric oxide.
• Neuroinflammation & Apoptosis: Microglial activation and proinflammatory cytokine cascades (TNF-alpha, IL-1beta) activate caspase-3-dependent apoptotic and necrotic cell death pathways, leading to permanent cortical, basal ganglia, and thalamic necrosis.

---

Clinical Staging: Sarnat Criteria for Neonatal Encephalopathy

Clinical grading using the modified Sarnat and Sarnat staging system distinguishes mild encephalopathy from moderate and severe forms that warrant therapeutic hypothermia.

---

Strict Criteria for Therapeutic Hypothermia Eligibility

Therapeutic hypothermia protocols established in landmark randomized clinical trials (NICHD, CoolCap, TOBY) require meeting three specific gating categories (Criteria A, B, and C) strictly within 6 hours of birth:

Criterion A: Gestational Age & Birth Weight

• Gestational age $\ge 35$ or $\ge 36$ completed weeks.
• Birth weight $\ge 1,800 \text{ grams}$.

Criterion B: Biochemical or Resuscitative Evidence of Acute Perinatal Asphyxia

The infant must meet at least one of the following physiological markers:

1. Severe Acidosis: Umbilical cord blood gas or any postnatal blood gas (arterial, venous, or capillary) obtained within the first 60 minutes of life demonstrating a pH $\le 7.00$ OR a base deficit $\ge 16 \text{ mmol/L}$.
2. Moderate Acidosis with Resuscitation Burden: If blood gas pH is 7.01 to 7.15 OR base deficit is 10.0 to 15.9 mmol/L, OR if a blood gas is completely unavailable, the patient must meet at least one acute historical/resuscitative criterion:
   • An acute perinatal sentinel event (e.g., uterine rupture, placental abruption, umbilical cord prolapse, vasa previa hemorrhage, fetal deceleration with non-reassuring fetal heart rate tracing); AND
   • A 10-minute Apgar score $\le 5$; OR
   • An ongoing need for assisted positive pressure ventilation (endotracheal or mask) initiated at birth and continued for at least 10 consecutive minutes.

Criterion C: Documented Moderate or Severe Encephalopathy

The infant must demonstrate either:

1. Clinical or electrographic seizures; OR
2. Altered level of consciousness (lethargy, stupor, or coma) PLUS documented abnormalities in at least one of the following neurological categories:
   • Abnormal tone (marked hypotonia or flaccidity);
   • Abnormal primitive reflexes (absent or severely depressed suck or Moro);
   • Autonomic dysfunction (abnormal pupils, bradycardia, or irregular respirations).

---

Transport Hypothermia Protocols: Active vs. Passive Cooling

Initiating cooling during transport saves vital latent phase time, but must be executed with extreme clinical precision.

Passive Cooling (Uncontrolled Transport)

Passive cooling involves turning off external heat sources (radiant warmers or transport isolette heaters), undressing the infant, unswaddling, and opening incubator access ports to allow ambient radiative and convective heat loss.

• Operational Hazards: Highly unpredictable. Ambient vehicle temperatures fluctuating between winter ramps and overheated ambulance cabins cause severe temperature instability. Passive cooling carries a dangerous risk of uncontrolled overcooling ($<32.0$ °C) or accidental warming.
• Protocol: If passive cooling is used while awaiting specialized transport arrival, the radiant warmer must be turned completely off, but the infant should have a continuous core rectal probe inserted. The warmer should be set to manual mode at low output if core temperature drops toward 33.5 °C.

Active Cooling (Servo-Controlled Transport)

Active cooling employs a specialized, mobile, servo-controlled cooling blanket or fluid-circulating wrap connected directly to a central thermal processing unit.

• Servo-Regulation: The system continuously reads core temperature via a rectal or esophageal probe and modulates circulating fluid temperature dynamically (adjusting water between 4 °C and 40 °C) to maintain core body temperature at exactly the programmed setpoint.
• Superiority: Active servo-controlled cooling minimizes thermal volatility, completely prevents accidental overcooling, and ensures the neonate arrives at the tertiary hypothermia center within the exact therapeutic range.

---

Core Temperature Monitoring Standards

• Target Core Temperature: 33.5 °C (strict therapeutic window: 33.0 °C to 34.0 °C).
• Monitoring Modality: Continuous core temperature measurement is mandatory. A dedicated rectal temperature probe must be lubricated, inserted gently to a depth of 2 to 3 cm beyond the anal sphincter, and securely taped to the infant's inner thigh. Alternatively, a mid-to-lower esophageal probe placed at the level of the lower third of the esophagus may be utilized in intubated infants.
• Contraindicated Methods: Skin probes and intermittent axillary temperature measurements are strictly contraindicated for titration of therapeutic hypothermia. Due to severe cold-induced peripheral vasoconstriction, cutaneous and axillary temperatures read 1.5 °C to 3.0 °C lower than actual central visceral core temperature, leading clinicians to falsely withhold cooling or dangerously overheat an infant.

---

Overcooling Hazards (<32.0 °C) & Clinical Countermeasures

Allowing core temperature to fall below 32.0 °C introduces severe multisystem physiological hazards:

Core Temp <33.0°C ──> Increased risk of arrhythmia & pulmonary hypertension
Core Temp <32.0°C ──> Severe bradycardia (<80 bpm), prolonged QT, hypotension
Core Temp <30.0°C ──> Ventricular fibrillation, profound coagulopathy, cardiac arrest

Physiological Consequences of Overcooling

1. Cardiovascular Collapse: Physiologic cooling decreases heart rate by approximately 10 to 14 bpm per 1.0 °C drop in core temperature. Cooled neonates normally exhibit heart rates of 80 to 100 bpm. Overcooling ($<32.0$ °C) causes profound sinus bradycardia ($<70-80$ bpm), prolongation of PR and QTc intervals, severe myocardial depression, hypotension, and fatal ventricular arrhythmias.
2. Exacerbation of PPHN: Hypothermia below 33.0 °C causes potent pulmonary vasoconstriction. In asphyxiated neonates with pre-existing parenchymal lung injury, this triggers catastrophic persistent pulmonary hypertension of the newborn (PPHN), severe right-to-left shunting across the ductus arteriosus and foramen ovale, and refractory hypoxemia.
3. Coagulopathy & Bleeding: Hypothermia inhibits platelet aggregation, impairs the enzymatic clotting cascade, and prolongs PT/INR and PTT. Overcooled neonates suffer pulmonary hemorrhage and extension of intracranial hemorrhages.
4. Metabolic & Renal Derangements: Decreased tubular function causes severe cold diuresis or acute tubular necrosis with oliguria. Potassium shifts intracellularly during cooling, causing hypokalemia. Rapid rewarming triggers sudden extracellular potassium rebound and lethal hyperkalemia.

Management of Overcooling in Transit

If core temperature falls below 32.5 °C, active cooling must be paused immediately. If temperature falls below 32.0 °C, active controlled rewarming must be initiated at a rate not exceeding 0.5 °C per hour using radiant warmth or incubator air. Rapid rewarming causes abrupt systemic vasodilation, profound hypotension, reduced cerebral perfusion pressure, and secondary brain reperfusion injury.

---

Shivering Recognition & Management

Shivering is an involuntary physiological thermogenic response to cold stress that completely defeats the neuroprotective goals of therapeutic hypothermia.

• Pathophysiology: Shivering increases total metabolic rate by 100% to 300%, markedly elevates oxygen consumption, surges carbon dioxide production, triggers metabolic acidosis, and spikes intracranial pressure (ICP).
• Clinical Identification: Shivering in neonates manifests as fine muscular tremors, micro-vibrations palpable over the pectoral and masseter muscles, high-frequency baseline artifact on cardiac EKG monitors, and unexplained elevations in end-tidal CO2.
• Pharmacologic Suppression:
  • Morphine Sulfate: Continuous infusion of 10 to 20 mcg/kg/hr (or intermittent boluses of 0.05 to 0.1 mg/kg IV) provides analgesia, suppresses the hypothalamic shivering setpoint, and reduces metabolic stress.
  • Fentanyl: 1 to 2 mcg/kg IV as an alternative rapid-acting opioid.
  • Dexmedetomidine / Sedation: Selective alpha-2 agonists may be titrated under protocolized medical direction.
  • Neuromuscular Blockade (e.g., Vecuronium): Strictly reserved for intubated, fully ventilated infants with violent shivering refractory to opioids. Paralytics abolish motor shivering but mask clinical seizure activity; continuous electrographic monitoring is mandatory.

---

Clinical Pearl: Rectal Probe Migration & The Overcooling Trap

Clinical Pearl: Secure Rectal Probe Placement

A displaced rectal temperature probe is a lethal transport pitfall. If a rectal probe slips partially out of the rectum into ambient cool air, the monitor displays a falsely low reading (e.g., 29.5 °C). An inexperienced clinician might abruptly apply radiant heat, dangerously hypertherming an ischemic brain. Conversely, if an un-servo-controlled baby has a probe migrate into a warm diaper fold, the clinician may apply aggressive cooling, driving real visceral core temperature into lethal ventricular fibrillation territory (<30.0 °C). Always confirm probe insertion depth (2 to 3 cm) and tape securely to the inner thigh before initiating transport.